anti-CD137 (TNFRSF9) Antikörper

anti-Tumor Necrosis Factor Receptor Superfamily, Member 9 Antikörper (TNFRSF9)
Auf finden Sie aktuell 326 Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Antikörper von 23 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen CD137 Proteine (62) und CD137 Kits (28) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 426 CD137 Produkte verfügbar.
4-1BB, A930040I11Rik, AA408498, AI325004, Cd137, CDw137, ILA, Ly63, TNFRSF9, zgc:136557
Alle Antikörper anzeigen Gen GeneID UniProt
TNFRSF9 3604 Q07011
TNFRSF9 21942 P20334

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-CD137 (TNFRSF9) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human CD137 Antikörper:

anti-Mouse (Murine) CD137 Antikörper:

anti-Rat (Rattus) CD137 Antikörper:

Alle verfügbaren anti-CD137 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-CD137 Antikörper

  1. Human Monoclonal CD137 Primary Antibody für FACS, IF - ABIN2663017 : Alderson, Smith, Tough, Davis-Smith, Armitage, Falk, Roux, Baker, Sutherland, Din: Molecular and biological characterization of human 4-1BB and its ligand. in European journal of immunology 1994 (PubMed)
    Zeige alle 8 Referenzen für 2663017

  2. Human Monoclonal CD137 Primary Antibody für FACS - ABIN2665542 : Schwarz, Blanco, von Kempis, Valbracht, Lotz: ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. in Blood 1996 (PubMed)
    Zeige alle 8 Referenzen für 2665542

  3. Human Monoclonal CD137 Primary Antibody für FACS - ABIN2657240 : Gruss, Dower: Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. in Blood 1995 (PubMed)
    Zeige alle 8 Referenzen für 2657240

  4. Human Monoclonal CD137 Primary Antibody für FACS - ABIN2660941 : Sica, Chen: Modulation of the immune response through 4-1BB. in Advances in experimental medicine and biology 2000 (PubMed)
    Zeige alle 8 Referenzen für 2660941

  5. Human Monoclonal CD137 Primary Antibody für Func, FACS - ABIN610408 : Boulton, Cobb: Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. in Cell regulation 1991 (PubMed)
    Zeige alle 4 Referenzen für 610408

  6. Human Polyclonal CD137 Primary Antibody für IF (p), IHC (p) - ABIN740445 : Daquinag, Tseng, Salameh, Zhang, Amaya-Manzanares, Dadbin, Florez, Xu, Tong, Kolonin: Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development. in Cell death and differentiation 2014 (PubMed)
    Zeige alle 2 Referenzen für 740445

  7. Human Polyclonal CD137 Primary Antibody für ELISA (Detection), FACS - ABIN4899793 : Lindstedt, Johansson-Lindbom, Borrebaeck: Expression of CD137 (4-1BB) on human follicular dendritic cells. in Scandinavian journal of immunology 2003 (PubMed)

  8. Human Polyclonal CD137 Primary Antibody für ELISA, WB - ABIN1533841 : Schwarz, Tuckwell, Lotz: A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. in Gene 1994 (PubMed)

Weitere Antikörper gegen CD137 Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Interaktionspartner

  1. Egr2 (zeige EGR2 Antikörper)-driven cell surface proteins LAG-3 (zeige LAG3 Antikörper) and 4-1BB can identify dysfunctional tumor antigen-specific CD8 (zeige CD8A Antikörper)(+) TIL (zeige TLR1 Antikörper).

  2. Findings indicate that CD137 antigen is a useful marker that can be used for identifying Mycobacterium tuberculosis (Mtb (zeige NCAPG2 Antikörper))-reactive CD4 (zeige CD4 Antikörper)(+) T cells (Mtb (zeige NCAPG2 Antikörper)-reactive CD4 (zeige CD4 Antikörper)(+) T cells) by flow cytometry.

  3. Anti-4-1BB single chain variable fragments enhanced surface CD69 (zeige CD69 Antikörper) expression and interleukin-2 (zeige IL2 Antikörper) production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.

  4. Studies suggest that adoptive T cell therapy and CD137 antigen offer much opportunity to raise the efficacy of current cancer immunotherapies.

  5. Triple costimulation via CD80 (zeige CD80 Antikörper), 4-1BB, and CD83 (zeige CD83 Antikörper) ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 (zeige IL2 Antikörper).

  6. These studies provide the first direct evidence that ligation of tumour necrosis factor (zeige TNF Antikörper) superfamily members and their cognate receptors is important for the control of viral lytic replication.

  7. Our findings provide a novel, TNFRSF9-positive, reactive astrocytic phenotype in human gliomas

  8. Human genetic evidence for involvement of CD137 in atherosclerosis

  9. As a result of becoming activated, transferred human T lymphocytes express the inducible surface antigens hPD-1 (zeige PDCD1 Antikörper) and hCD137 on their plasma membrane.

  10. Our results provide biological explanations for the antitumor effects of CD19 (zeige CD19 Antikörper) CARs and for the observations that CD19 (zeige CD19 Antikörper) CAR T cells incorporating the 4-1BB costimulatory domain are more persistent than those incorporating CD28 (zeige CD28 Antikörper) in clinical trials.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Interaktionspartner

  1. results indicate that one important diabetogenic function of CD137 is to promote the expansion and accumulation of beta cell-autoreactive CD8 (zeige CD8A Antikörper) T cells, and in the absence of CD137 or its interaction with CD137 ligand, type 1 diabetes progression is suppressed

  2. High CD137 expression is associated with neoplasms.

  3. Ly6C, 4-1BB, and KLRG1 (zeige KLRG1 Antikörper) have roles in the activation of lamina propria lymphocytes in the small intestine in a mouse model of Crohn's disease

  4. CD137 Regulates NFATc1 (zeige NFATC1 Antikörper) Expression in Mouse VSMCs through TRAF6 (zeige TRAF6 Antikörper)/NF-kappaB (zeige NFKB1 Antikörper) p65 (zeige NFkBP65 Antikörper) Signaling Pathway.

  5. 4-1BB triggering preferentially enhances the expansion of CD8 (zeige CD8A Antikörper)+ T cells through the amplification of autocrine IL-2 (zeige IL2 Antikörper)/IL-2R signaling loop.

  6. c-IAP (zeige ALPI Antikörper) ubiquitin protein ligase (zeige UBE2K Antikörper) activity is required for 4-1BB signaling and CD8 (zeige CD8A Antikörper)(+) memory T-cell survival.

  7. we conclude that in vivo 4-1BB signaling of myeloid cells negatively regulates peripheral T cell responses

  8. activation of CD137 signaling decreases the stability of advanced atherosclerotic plaques via its combined effects on Teff cells, vascular smooth muscle cells, and macrophages

  9. 4-1BB mediates the inflammatory responses in obese skeletal muscle by interacting with its ligand 4-1BBL (zeige TNFSF9 Antikörper) on macrophages.

  10. CD137-CD137L (zeige TNFSF9 Antikörper) interactions mediated via regulation of CyPA (zeige PPIA Antikörper) contribute to the progression of atherosclerosis.

CD137 (TNFRSF9) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.

Alternative names and synonyms associated with CD137 (TNFRSF9)

  • tumor necrosis factor receptor superfamily, member 9 (TNFRSF9) Antikörper
  • tumor necrosis factor receptor superfamily, member 9a (tnfrsf9a) Antikörper
  • tumor necrosis factor receptor superfamily, member 9 (LOC100348914) Antikörper
  • tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9) Antikörper
  • 4-1BB Antikörper
  • A930040I11Rik Antikörper
  • AA408498 Antikörper
  • AI325004 Antikörper
  • Cd137 Antikörper
  • CDw137 Antikörper
  • ILA Antikörper
  • Ly63 Antikörper
  • TNFRSF9 Antikörper
  • zgc:136557 Antikörper

Bezeichner auf Proteinebene für TNFRSF9

tumor necrosis factor receptor superfamily, member 9 , tumor necrosis factor receptor superfamily member 9 , 4-1BB ligand receptor , CD137 antigen , T cell antigen ILA , T-cell antigen 4-1BB homolog , T-cell antigen ILA , homolog of mouse 4-1BB , induced by lymphocyte activation (ILA) , interleukin-activated receptor, homolog of mouse Ly63 , receptor protein 4-1BB , T-cell antigen 4-1BB , secreted CD137 antigen

419365 Gallus gallus
520341 Bos taurus
608274 Canis lupus familiaris
678622 Danio rerio
708281 Macaca mulatta
746029 Pan troglodytes
100196937 Papio anubis
100348914 Oryctolagus cuniculus
3604 Homo sapiens
21942 Mus musculus
Ausgewählte Anbieter für anti-CD137 (TNFRSF9) Antikörper
Haben Sie etwas anderes gesucht?